BAC
77
5
PSA
35
-11
CMI
71
2
ACN
56
2
BRK.B
33
-14
QCOM
45
2
TGNA
53
-3
IP
28
-3
CRM
70
18
PCG
74
2
NFLX
40
3
OI
47
-11
AVGO
54
12
HD
28
-4
MMM
56
2
L
71
2
PGR
42
2
DTE
38
-4
FFIV
47
-3
MPC
38
2
BAC
77
5
PSA
35
-11
CMI
71
2
ACN
56
2
BRK.B
33
-14
QCOM
45
2
TGNA
53
-3
IP
28
-3
CRM
70
18
PCG
74
2
NFLX
40
3
OI
47
-11
AVGO
54
12
HD
28
-4
MMM
56
2
L
71
2
PGR
42
2
DTE
38
-4
FFIV
47
-3
MPC
38
2
Financhill
Back

Sino Biopharmaceutical Ltd. 10K Form

Buy
54

SBHMY
Sino Biopharmaceutical Ltd.

Last Price:
$18.22
Seasonality Move:
-3.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SBHMY News And Ratings

See the #1 stock for the next 7 days that we like better than SBHMY

SBHMY Financial Statistics

Sales & Book Value

Annual Sales: $4B
Cash Flow: $0
Price / Cash Flow: 14.88
Annual Sales: $4.81
Price / Book: 4.29

Profitability

EPS (TTM): 0.59510
Net Income (TTM): $935.8M
Gross Margin: $3.3B
Return on Equity: 8.57%
Return on Assets: 5.38%

Sino Biopharmaceutical Ltd. Earnings Forecast

Key Sino Biopharmaceutical Ltd. Financial Ratios

  • The Gross Profit Margin over the past 26 years for SBHMY is 81.51%.
  • The Selling, General & Administrative Expenses for SBHMY have been equal to 42.12% of Gross Profit Margin.
  • The Research & Development expenses have been 17.63% of Revenue.
  • The Interest Expense is 6.17% of Operating Income.
  • The Net Earning history of SBHMY is 16.57% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

Sino Biopharmaceutical Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SBHMY
Website: sinobiopharm.com

Debt

Debt-to-Equity Ratio: 0.3
Current Ratio: 1.26
Quick Ratio: 1.14

Price-to-Earnings

Trailing P/E Ratio: 67.01
Forward P/E Ratio: 0

SBHMY Technical Analysis vs Fundamental Analysis

Buy
54
Sino Biopharmaceutical Ltd. (SBHMY) is a Buy

Is Sino Biopharmaceutical Ltd. a Buy or a Sell?